References
- Sattler FR, Castaneda-Sceppa C, Binder EF et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J. Clin. Endocrinol. Metab.94(6), 1991–2001 (2009).
- Blackman MR, Sorkin JD, Munzer T et al. Growth hormone and sex steroid administration in healthy aged women and men. JAMA288, 2282–2292 (2002).
- Giannoulis MG, Sonksen PH, Umpleby M et al. The effects of growth hormone and/or testosterone in healthy older men: a randomised controlled trial. J. Clin. Endocrinol. Metab.91, 477–484 (2006).
- Veldhuis J, Keenan DM, Mielke K, Miles JM, Bowers CY. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy. Eur. J. Endocrinol.153, 577–586 (2005).
- Veldhuis JD. Aging and hormones of the hypothalamo–pituitary axis: gonadotropic axis in men and somatotropic axes in men and women. Ageing Res. Rev.7, 189–208 (2008).
- Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev.26, 833–876 (2005).
- Yeap BB. Are declining testosterone levels a major risk factor for ill-health in aging men? Int. J. Impot. Res.21, 24–36 (2009).
- Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin. Endocrinol.69, 347–358 (2008).
- Burnett-Bowie SA, Roupenian KC, Dere ME, Lee H, Leder BZ. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial. Clin. Endocrinol.70, 116–123 (2009).
- White HK, Petrie CD, Landschulz W et al. Effects of an oral growth hormone secretagogue in older adults. J. Clin. Endocrinol. Metab.94, 1198–1206 (2009).